Free Trial

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) Sees Large Decrease in Short Interest

Curaleaf logo with Medical background

Curaleaf Holdings, Inc. (OTCMKTS:CURLF - Get Free Report) saw a large drop in short interest in the month of December. As of December 31st, there was short interest totalling 6,765,700 shares, a drop of 6.6% from the December 15th total of 7,246,500 shares. Based on an average daily volume of 1,464,200 shares, the days-to-cover ratio is currently 4.6 days.

Curaleaf Price Performance

Shares of OTCMKTS CURLF traded up $0.14 during mid-day trading on Friday, reaching $1.51. The company had a trading volume of 597,523 shares, compared to its average volume of 631,758. The company has a current ratio of 1.11, a quick ratio of 0.51 and a debt-to-equity ratio of 0.85. The stock has a market cap of $981.33 million, a PE ratio of -5.21 and a beta of 0.64. The company has a 50-day moving average price of $1.72 and a two-hundred day moving average price of $2.73. Curaleaf has a 1-year low of $0.88 and a 1-year high of $6.40.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on the company. Roth Capital upgraded Curaleaf to a "strong-buy" rating in a research report on Sunday, November 10th. Cormark cut Curaleaf from a "moderate buy" rating to a "hold" rating in a research report on Thursday, November 7th.

Check Out Our Latest Stock Analysis on CURLF

Curaleaf Company Profile

(Get Free Report)

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.

Featured Articles

Should You Invest $1,000 in Curaleaf Right Now?

Before you consider Curaleaf, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Curaleaf wasn't on the list.

While Curaleaf currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in February 2025
How To Invest in Crypto as A Complete BEGINNER in 2025
3 AI Bargain Stocks to BUY NOW After the DeepSeek Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines